"The realization was you could do a better job having a biotech company, " says CHDI Chief Executive Robert Pacifici.

FORBES: Magazine Article

It wouldn't be doing so were it not for the Cure Huntington's Disease Initiative, a group that in 2004 turned itself into a biotech called CHDI.

FORBES: Magazine Article